Summary
- Current Price
- As of today, RNAZ price is $5.35, down -3.43% on
- Current Price All-Time High
- RNAZ price is currently -100.00% below its historical high of $5,174,400.00 set on
- Market Cap
- RNAZ current market cap is $5M, down -12.62% year-over-year
- PE Ratio
- RNAZ PE ratio is unknown
- Revenue
- RNAZ current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- As of today, the next earnings release for RNAZ has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | TransCode Therapeutics, Inc. |
| Ticker | NASDAQ: RNAZ |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | transcodetherapeutics.com |
| Employees | 7 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $5.35 | ||
| Price, 1D Change | -3.43% | |
| $5M | ||
| - | ||
| - | ||
| 0.94 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$52.59 | ||
| EPS, 1Y Change | +96.01% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | N/A | |
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:28 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$52.59 | ||
| EPS Estimate | N/A | -$0.32 |
| EPS Est. Change | N/A | +99.39% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| $5.35 | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$222.80 | -$3,419.00 | -1,434.56% | |
| -$4.76 | -$1,317.38 | -27,576.08% | |
| - | -$52.59 | - | |
| -$0.32 | N/A | +99.39% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| $300.00K | $0.00 | -100.00% | |
| - | $0.00 | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -23.35% | ||
| -99.99% | ||
| -12.62% | ||
| -91.01% | ||
| 0.00% | ||
| 0.00% | ||
| +96.01% | ||
| +99.85% |
🔒 Log In To Unlock Full Data
Technicals
| Metric | Date | Value |
|---|---|---|
| $5.35 | ||
| $9.17 | ||
| $6.96 | ||
| $333.86 | ||
| $6.66 | ||
| -$0.42 | ||
| 0.94 | ||
| $0.70 | ||
| 41.21 | ||
| 122.21% | ||
| 91.34% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$52.59 | ||
| -$114.20K | ||
| - | ||
| -$19.19M | ||
| - | ||
| -$34.66M | ||
| - | ||
| -$19.08M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 6.29 | ||
| 6.29 | ||
| - | ||
| - | ||
| -0.81 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 4.06 | ||
| 0.33 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $10.34M | ||
| $17.81M | ||
| $162.40M | ||
| $21.98M | ||
| $10.52M | ||
| $3.49M | ||
| $0.00 | ||
| $0.00 | ||
| $3.12M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $34.66M | ||
| $19.08M | ||
| $114.20K | ||
| $0.00 | ||
| $114.20K | ||
| $0.00 | ||
| $226.10K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$19.52M | ||
| -$4,400.00 | ||
| $31.52M | ||
| $6,700.00 | ||
| -$19.52M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → |
Analyst sentiment
Institutional ownership
Screeners with RNAZ
FAQ
What is the ticker symbol for TransCode Therapeutics, Inc.?
The ticker symbol for TransCode Therapeutics, Inc. is NASDAQ:RNAZ
Does TransCode Therapeutics, Inc. pay dividends?
No, TransCode Therapeutics, Inc. does not pay dividends
What sector is TransCode Therapeutics, Inc. in?
TransCode Therapeutics, Inc. is in the Healthcare sector
What industry is TransCode Therapeutics, Inc. in?
TransCode Therapeutics, Inc. is in the Biotechnology industry
What country is TransCode Therapeutics, Inc. based in?
TransCode Therapeutics, Inc. is headquartered in United States
When did TransCode Therapeutics, Inc. go public?
TransCode Therapeutics, Inc. initial public offering (IPO) was on July 8, 2021
Is TransCode Therapeutics, Inc. in the S&P 500?
No, TransCode Therapeutics, Inc. is not included in the S&P 500 index
Is TransCode Therapeutics, Inc. in the NASDAQ 100?
No, TransCode Therapeutics, Inc. is not included in the NASDAQ 100 index
Is TransCode Therapeutics, Inc. in the Dow Jones?
No, TransCode Therapeutics, Inc. is not included in the Dow Jones index
When was TransCode Therapeutics, Inc. last earnings report?
TransCode Therapeutics, Inc.'s most recent earnings report was on May 16, 2022
When does TransCode Therapeutics, Inc. report earnings?
The date for TransCode Therapeutics, Inc.'s next earnings report has not been announced yet
Data Sources & References
- RNAZ Official Website www.transcodetherapeutics.com
- RNAZ Profile on Yahoo Finance finance.yahoo.com/quote/RNAZ
- RNAZ Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rnaz